Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Metabolites ; 12(11)2022 Oct 26.
Artigo em Inglês | MEDLINE | ID: mdl-36355110

RESUMO

Cysteine proteases obtained from the stem of pineapple or papaya latex, bromelain and papain, respectively, exhibit a broad spectrum of beneficial effects on human health. However, their effects on gut microbiota composition or dose-manner effects on the intestinal integrity of healthy tissue have not been evaluated. In this study, C57BL/6 young, healthy mice were fed bromelain or papain in a dose of 1 mg per animal/day for three consecutive days, followed by the assessment of digestive protein capacity, intestinal morphology and gut microbiota composition. Furthermore, a human reconstructed 3D tissue model EpiIntestinal (SMI-100) was used to study the effects of 1, 0.1 and 10 mg/mL doses of each enzyme on tissue integrity and mucosal permeability using TEER measurements and passage of Lucifer Yellow marker from the apical to the basolateral side of the mucosa. The results indicated that fruit proteases have the potential to modulate gut microbiota with decreasing abundance of Proteobacteria and increasing beneficial Akkermansia muciniphila. The enhancement of pancreatic trypsin was observed in bromelain and papain supplementation, while bromelain also increased the thickness of the ileal mucosa. Furthermore, an in vitro study showed a dose-dependent interruption in epithelial integrity, which resulted in increased paracellular permeability by the highest doses of enzymes. These findings define bromelain and papain as promising enzymatic supplementation for controlled enhancement of paracellular uptake when needed, together with beneficial effects on the gut microbiota.

2.
PLoS One ; 10(2): e0116947, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25658606

RESUMO

OBJECTIVES: Postnatal gut maturation in neonatal mammals, either at natural weaning or after precocious inducement, is coinciding with enhanced enzymes production by exocrine pancreas. Since the involvement of enzymes in gut functional maturation was overlooked, the present study aimed to investigate the role of enzymes in gut functional maturation using neonatal rats. METHODS: Suckling rats (Rattus norvegicus) were instagastrically gavaged with porcine pancreatic enzymes (Creon), microbial-derived amylase, protease, lipase and mixture thereof, while controls received α-lactalbumin or water once per day during 14-16 d of age. At 17 d of age the animals were euthanized and visceral organs were dissected, weighed and analyzed for structural and functional properties. For some of the rats, gavage with the macromolecular markers such as bovine serum albumin and bovine IgG was performed 3 hours prior to blood collection to assess the intestinal permeability. RESULTS: Gavage with the pancreatic or pancreatic-like enzymes resulted in stimulated gut growth, increased gastric acid secretion and switched intestinal disaccharidases, with decreased lactase and increased maltase and sucrase activities. The fetal-type vacuolated enterocytes were replaced by the adult-type in the distal intestine, and macromolecular transfer to the blood was declined. Enzyme exposure also promoted pancreas growth with increased amylase and trypsin production. These effects were confined to the proteases in a dose-dependent manner. CONCLUSION: Feeding exogenous enzymes, containing proteases, induced precocious gut maturation in suckling rats. This suggests that luminal exposure to proteases by oral loading or, possibly, via enhanced pancreatic secretion involves in the gut maturation of young mammals.


Assuntos
Intestinos/crescimento & desenvolvimento , Pâncreas/enzimologia , Peptídeo Hidrolases/farmacologia , Animais , Animais Recém-Nascidos , Peso Corporal/efeitos dos fármacos , Bovinos , Relação Dose-Resposta a Droga , Feminino , Ácido Gástrico/metabolismo , Imunoglobulina G/sangue , Intestinos/efeitos dos fármacos , Tamanho do Órgão/efeitos dos fármacos , Ratos Sprague-Dawley , Soroalbumina Bovina/análise , Sus scrofa
3.
Br J Nutr ; 112(12): 2060-7, 2014 Dec 28.
Artigo em Inglês | MEDLINE | ID: mdl-25348808

RESUMO

The maldigestion and malabsorption of fat in infants fed milk formula results due to the minimal production of pancreatic lipase. Thus, to investigate lipid digestion and absorption and mimic the situation in newborns, a young porcine exocrine pancreatic insufficient (EPI) model was adapted and validated in the present study. A total of thirteen EPI pigs, aged 8 weeks old, were randomised into three groups and fed either a milk-based formula or a milk-based formula supplemented with either bacterial or fungal lipase. Digestion and absorption of fat was directly correlated with the addition of lipases as demonstrated by a 30% increase in the coefficient of fat absorption. In comparison to the control group, a 40 and 25% reduction in total fat content and 26 and 45% reduction in n-3 and n-6 fatty acid (FA) content in the stool was observed for lipases 1 and 2, respectively. Improved fat absorption was reflected in the blood levels of lipid parameters. During the experiment, only a very slight gain in body weight was observed in EPI piglets, which can be explained by the absence of pancreatic protease and amylase in the gastrointestinal tract. This is similar to newborn babies that have reduced physiological function of exocrine pancreas. In conclusion, we postulate that the EPI pig model fed with infant formula mimics the growth and lipid digestion and absorption in human neonates and can be used to elucidate further importance of fat and FA in the development and growth of newborns, as well as for testing novel formula compositions.


Assuntos
Gorduras Insaturadas na Dieta/metabolismo , Digestão , Modelos Animais de Doenças , Insuficiência Pancreática Exócrina/metabolismo , Fórmulas Infantis , Absorção Intestinal , Lipase/deficiência , Animais , Peso Corporal , Insuficiência Pancreática Exócrina/etiologia , Ácidos Graxos Ômega-3/metabolismo , Ácidos Graxos Ômega-6/metabolismo , Fezes , Trato Gastrointestinal/metabolismo , Crescimento , Humanos , Recém-Nascido , Ligadura , Lipase/farmacologia , Metabolismo dos Lipídeos , Masculino , Leite , Pâncreas Exócrino , Ductos Pancreáticos/cirurgia , Distribuição Aleatória , Suínos
4.
Adv Med Sci ; 59(1): 74-80, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24797979

RESUMO

PURPOSE: Exocrine pancreatic insufficiency (EPI) induced in young pigs by pancreatic duct ligation (PDL) early after weaning result in total growth deprivation while it has little effect in somewhat older pigs. The main objective was to study effects of EPI on gut structure and function in littermate pigs underwent to PDL at different age. MATERIAL/METHODS: Pigs, duct-ligated at either 7 (2 weeks post-weaning, PDL-7) or 16 weeks of age (PDL-16), and euthanized at an age of 21-23 weeks together with un-operated littermates were studied. The intestinal in vitro permeability was studied in separate PDL-pigs and compared to un-operated. RESULTS: Morphometric analysis showed gut mucosal atrophy in the PDL-7 as compared to PDL-16 pigs, while no differences in mucosal disaccharidase activities. The intestinal permeability for different-sized markers was significantly increased in the PDL-pigs compared to the un-operated controls. Analyses of the intestinal digesta showed a total lack of pancreatic enzymes in all PDL-pigs, while instead new, as yet unidentified, enzyme-activities appeared. CONCLUSIONS: All EPI-pigs, independent of age at PDL-operation, displayed adaptive gut changes, however the EPI-pigs operated early after weaning appeared more sensitive, probably related to their gut maturity and possibly explaining the growth arrest seen in these pigs.


Assuntos
Insuficiência Pancreática Exócrina/fisiopatologia , Trato Gastrointestinal/crescimento & desenvolvimento , Trato Gastrointestinal/patologia , Transtornos do Crescimento/etiologia , Ligadura/efeitos adversos , Ductos Pancreáticos/cirurgia , Doenças dos Suínos/fisiopatologia , Animais , Insuficiência Pancreática Exócrina/complicações , Transtornos do Crescimento/patologia , Suínos , Fatores de Tempo , Desmame
5.
Clin Nutr ; 28(3): 325-30, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19297056

RESUMO

BACKGROUND & AIMS: Young individuals with exocrine pancreatic insufficiency (EPI) show growth reduction that can be reversed by dietary pancreatic enzyme supplementation. Here we investigated whether feeding an elemental diet could replace the growth-promoting effect of enzyme supplementation in EPI pigs. METHODS: Weaned pigs with intact pancreas (control) or pancreatic duct-ligated (EPI pigs) were given a commercial pig feed, a fat-enriched diet, or an elemental diet, intragastrically and intravenously, with or without porcine pancreatin (Creon) supplementation for 1 week. RESULTS: Control pigs, irrespective of receiving pig feed or an elemental diet, increased their body weight by 13.4-20.1%, while EPI pigs showed negligible weight gain. Giving a fat-enriched diet did not improve growth of the EPI pigs. However, if the EPI pigs were supplemented with pancreatin in combination with fat-enriched feed or the elemental diet, i.v., their body weight increased by 16.6 %and 8.5%, respectively. CONCLUSION: Control pigs maintained normal growth, independently of the diet being given in polymeric or elemental form, while EPI pigs showed impaired growth when receiving the same diets without enzyme supplementation. Pancreatic juice and enzyme preparations, in addition to their digestive properties, also appear to affect nutrient assimilation and anabolism in young individuals.


Assuntos
Insuficiência Pancreática Exócrina/terapia , Pâncreas/enzimologia , Pancreatina/uso terapêutico , Sus scrofa , Aumento de Peso/efeitos dos fármacos , Ração Animal , Animais , Gorduras na Dieta/administração & dosagem , Gorduras na Dieta/metabolismo , Modelos Animais de Doenças , Fármacos Gastrointestinais/uso terapêutico , Ligadura , Masculino , Pâncreas/metabolismo , Ductos Pancreáticos/cirurgia , Distribuição Aleatória , Sus scrofa/crescimento & desenvolvimento , Sus scrofa/metabolismo , Suínos
6.
Amino Acids ; 37(4): 637-41, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18836681

RESUMO

Kynurenic acid (KYNA) is an agonist of the G-protein-coupled receptor GPR35, which is predominantly expressed in gastrointestinal tissues. The aim of this study was to determine the content of KYNA in gastric juice, bile and pancreatic juice and intestinal content. KYNA was determined by means of high performance liquid chromatography. The mean concentrations of KYNA in human gastric juice is 9.91 +/- 0.71 nM in contrast to human bile (832.5 +/- 204.1 and 306.8 +/- 35.2 nM) obtained from patients with cholecystolithiasis and obstructive jaundice, respectively. In pigs, the KYNA levels in bile and pancreatic juice are 1,113.3 +/- 63.34 and 757.0 +/- 394.4 nM, respectively. The KYNA concentration increases along the digestive system, reaching 1,638 nM in the colon content. We suggest that the liver and pancreas affect the content of kynurenic acid in the lumen of the digestive tract.


Assuntos
Bile/química , Ácido Cinurênico/análise , Suco Pancreático/química , Animais , Bile/metabolismo , Colecistolitíase/metabolismo , Feminino , Suco Gástrico/química , Suco Gástrico/metabolismo , Conteúdo Gastrointestinal/química , Humanos , Icterícia Obstrutiva/metabolismo , Masculino , Pessoa de Meia-Idade , Suco Pancreático/metabolismo , Sus scrofa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA